This article is a correction to:
Therapeutically targeting type I interferon directly to XCR1+ dendritic cells reveals the role of cDC1s in anti-drug antibodies
Paul Noe1Joy H. Wang1Kyu Chung2Zhiyong Cheng1Jessica J. Field2
Xiaomeng Shen2Stephanie C. Casey1Christa L. Cortesio3Cinthia V. Pastuskovas2
Hyewon Phee1
Kristin V. Tarbell1
Jackson G. Egen1
Amy-Jo Casbon1*- 1Oncology Research, Amgen Research, South San Francisco, CA, United States
- 2Pharmacokinetics and Drug Metabolism, Amgen Research, South San Francisco, CA, United States
- 3Therapeutics Discovery, Amgen Research, South San Francisco, CA, United States
A Corrigendum on
Therapeutically targeting type I interferon directly to XCR1+ dendritic cells reveals the role of cDC1s in anti-drug antibodies
By Noe P, Wang JH, Chung K, Cheng Z, Field JJ, Shen X, Cortesio CL, Pastuskovas CV, Phee H, Tarbell KV, Egen JG, Casbon AJ (2023) Front. Immunol. 14:1272055. doi: 10.3389/fimmu.2023.1272055
In the published article, there was an error in the author list, and author Stephanie C. Casey was erroneously excluded. In addition, the wrong affiliation number was listed for Kyu Chung. The corrected author list appears below, along with the correct affiliations:
Paul Noe1, Joy H. Wang1, Kyu Chung2, Zhiyong Cheng1, Jessica J. Field2, Xiaomeng Shen2, Stephanie C. Casey1, Christa L. Cortesio3, Cinthia V. Pastuskovas2, Hyewon Phee1, Kristin V. Tarbell1, Jackson G. Egen1 and Amy-Jo Casbon1*
In the published article, there was an error in author contribution, and author Stephanie C. Casey, initials SC, was erroneously excluded. The corrected author contribution appears below:
PN: Data curation, Formal Analysis, Methodology, Writing – review & editing. JW: Data curation, Formal Analysis, Writing – review & editing. KC: Data curation, Formal Analysis, Writing – review & editing, Methodology. ZC: Writing – review & editing, Data curation, Formal Analysis. JF: Writing – review & editing, Data curation, Formal Analysis. XS: Data curation, Methodology, Writing – review & editing. SC: Methodology, Writing – review & editing. CC: Data curation, Formal Analysis, Methodology, Writing – review & editing, Supervision. CP: Data curation, Writing – review & editing, Formal Analysis, Methodology, Supervision. HP: Writing – review & editing, Conceptualization. KT: Writing – review & editing, Methodology. JE: Conceptualization, Writing – review & editing. A-JC: Conceptualization, Writing – review & editing, Data curation, Formal Analysis, Investigation, Methodology, Project administration, Supervision, Validation, Writing – original draft.
In the published article, there was an error in Supplementary Figures 3C and Supplementary Figures 5C. The study design in each figure incorrectly reports the tumor implantation date as d1 (day 1).
The correct supplemental material has been updated in the original article.
In the published article, there was an error. The formula for calculating tumor volume was incorrect.
A correction has been made to Materials and methods, 2.9 Murine tumor models. This sentence previously stated:
“tumor volume = 0.52 (length *width2)”
The corrected sentence appears below:
“tumor volume = l (length) x w (width) x h (height)”
A correction has also been made to Materials and methods, 2.1 Protein production. This sentence previously stated:
“fusions were made on a mIgG1-SEFL2 N297A backbone”
The corrected sentence appears below:
“fusions were made on a mIgG1-SEFL1 N297A backbone”
The authors apologize for these errors and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: immunogenicity, interferon, immunotherapy, dendritic cells, conventional type I DCs, antibody IFN fusion, pharmacokinetics
Citation: Noe P, Wang JH, Chung K, Cheng Z, Field JJ, Shen X, Casey SC, Cortesio CL, Pastuskovas CV, Phee H, Tarbell KV, Egen JG and Casbon A-J (2024) Corrigendum: Therapeutically targeting type I interferon directly to XCR1+ dendritic cells reveals the role of cDC1s in anti-drug antibodies. Front. Immunol. 15:1407085. doi: 10.3389/fimmu.2024.1407085
Received: 26 March 2024; Accepted: 11 June 2024;
Published: 24 June 2024.
Edited and Reviewed by:
Stephen Thomas Ferris, Saint Louis University, United StatesCopyright © 2024 Noe, Wang, Chung, Cheng, Field, Shen, Casey, Cortesio, Pastuskovas, Phee, Tarbell, Egen and Casbon. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Amy-Jo Casbon, YW15am8uY2FzYm9uQGdtYWlsLmNvbQ==